Search

everythinglearnresearchcommunity

for

Search:↓

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Finasteride works better for baldness in people with shorter gene repeats.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Finasteride may improve prostate cancer treatment outcomes.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The gel made of minoxidil and hydroxypropyl-β-cyclodextrin improves hair growth and is good for long-term use.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

New genetic insights have improved understanding of hair loss, leading to a new test and treatments, but more research is needed on the test and laser comb effectiveness.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Lespedeza cuneata extract may help treat enlarged prostate.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

The T-zone on the face has more androgen receptors and produces more oil than the U-zone.

Dutasteride and finasteride affect different cell types differently.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Blocking testosterone speeds up wound healing in males.

A gene called BMAL1 plays a role in controlling hair growth.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Analog 23 is a promising compound for prostate cancer treatment.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Women with hair loss have more androgen receptors in certain hair follicles.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.